UB Paderborn / Katalog / Suche / in CDI

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2010-04, Vol.615 (2), p.245-248

2010

Link zum Volltext

Verfügbarkeit prüfen

563 SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.191-191

2010

Link zum Volltext

Verfügbarkeit prüfen

421 IMMUNOPET IMAGING OF RENAL CELL CARCINOMA WITH 1241-AND 89ZR-LABELED ANTI-CAIX MONOCLONAL ANTIBODY CG250

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.153-154

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab

OC-0267 Imaging the effect of Atovaquone on the hypoxia-related marker CAIX in head and neck cancer models

PD-L1 microSPECT/CT imaging for longitudinal monitoring of PD-L1 expression in syngeneic and humanized mouse models for cancer

PO-0965: Imaging of the hypoxia related marker Carbonic Anhydrase IX in human head and neck cancer xenografts

OP0075 Sensitive Spect/CT Imaging of Synovial Fap Expression after Anti-IL-22 Treatment in Experimental Arthritis

931 Novel nanobody targeting prostate-specific membrane antigen: A promising tracer for imaging of prostate cancer

12 Phase II study of lutetium-177-labeled anti carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

389 Dual modality imaging of clear cell renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody 111Indium-G250-IRDye800CW

192 Combination therapy with sunitinib and 177-Lu-girentuximab in RCC

389 Dual modality imaging of clear cell renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody111 Indium-G250-IRDye800CW

MC13-0036 Dynamics of IGF-1R expression during endocrine breast cancer treatment

23 Multimodality imaging van het niercelcarcinoom

PD-0449: ImmunoSPECT with 111In-cetuximab-F(abí)2 to predict treatment response in HNSCC xenografts

980 Optimization of Lutetium-177-G250 radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model

336 Sorafenib decreases Indium-111-girentuximab tumor uptake in clear cell renal cell carcinoma patients

SP-0537 TRANSLATIONAL STUDIES ON PRETARGETED RADIOIMMUNOTHERAPY OF COLORECTAL CANCER

OC-0152 IMAGING OF EGFR WITH USPECT IN HEAD AND NECK CANCER XENOGRAFTS WITH 111-IN-LABELED CETUXIMAB-F(ABÍ)2

Non-glycosylated BMP-2 can induce ectopic bone formation at lower concentrations compared to glycosylated BMP-2

928 Targeting CAIX: Indium-111 labeled cG250 as a diagnostic tool for renal masses and lesions suspected for metastasis of clear cell renal cell carcinoma

269 OPTICAL IMAGING OF RENAL CELL CARCINOMA USING THE ANTI-CAIX MONOCLONAL ANTIBODY CG250

720 RADIOIMMUNOTHERAPY USING LUTETIUM-177 LABELLED MONOCLONAL ANTIBODY CG250 STABILISES PREVIOUSLY PROGRESSIVE ADVANCED RENAL CELL CARCINOMA

PP 46 In vivo imaging of modulation of IGF-1R expression in breast cancer models

Spatial resolution of the Inveon small-animal PET scanner for the entire field of view

563 SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA

421 IMMUNOPET IMAGING OF RENAL CELL CARCINOMA WITH 1241-AND 89ZR-LABELED ANTI-CAIX MONOCLONAL ANTIBODY CG250

Suchergebnisse filtern